You must be talking to the inventor of the spirometer.....he will be dark when the paradigm shift moves to wheeze detection Dr Decan.
Look forward to your comments when the company attracts manufacturing and disrtibution partners on products that have zero clinical need.
Obviously you haven't spoken to the Royal Melbourne Hospital who purchased the Pulmotrack for their department of Respiratory and Sleep Medicine needs announced on the 7th May........just another spivvy bit of news you must think???
There are those of us who have invested and believe in the Professor and his products and then there are market junkies like yourself who hold no stock but just wish to meddle.........enjoy your meddling weekend Dr Doom.....lol
KSX Price at posting:
4.4¢ Sentiment: LT Buy Disclosure: Held